Regions Financial Corp Seagen Inc. Transaction History

Regions Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$187.64 - $206.25 $4,128 - $4,537	-22 Reduced 1.36%	1,600 $307,000
Q1 2023 May 12, 2023	BUY	$127.59 - $203.08 $2,806 - $4,467	22 Added 1.38%	1,622 $328,000
Q2 2022 Jul 25, 2022	SELL	$108.81 - $179.33 $6,746 - $11,118	-62 Reduced 3.73%	1,600 $283,000
Q1 2021 Jun 02, 2021	BUY	$137.51 - $190.8 $228,541 - $317,109	1,662 New	1,662 $231,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Regions Financial Corp with notifications on news.